Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05735964

Use of Indocyanine Green During Primary Repair of Oesophageal Atresia and Distal Tracheo-oesophageal Fistula

This study aims to look at babies having a primary or delayed primary oesophageal repair for OA with dTOF to evaluate if using Indocyanine green (ICG) and near infrared fluorescence (NIRF) can decrease the rates of anastomotic leaks and/or predict which patients they will happen in. The latter evaluation would help counsel parents and mean that further research can evaluate if other tactics can prevent the leak being a moderate or severe problem. These may include, but not be limited to, extra anastomotic sutures, insertion of a chest drain at the time of surgery (if this had not previously been considered) delaying oral feeding or using medications to dry up the saliva prophylactically (these medications have been shown to reduce the length of time it takes leaks to seal). Any technique that can reduce leak rates in oesophageal atresia is to be welcomed.

Additionally ICG may artifactually affect both peripheral oxygen readings (cause a transient decrease) and cerebral near infrared spectroscopy (NIRS) values (cause a transient increase). This is due to the temporary, dose dependent, interference of the dye with the mechanism of action of the monitoring rather than a physiological effect on oxygen levels. To date there has been no study investigating the effects of ICG on oxygen saturation and cerebral NIRS in neonates undergoing OA and/or dTOF repair.

The theory is an extension from adult practice following oesophagectomy for cancer where there was a reduction in anastomotic leaks when using ICG/NIRF perfusion assessment. Another study in bariatric surgery using an enteral ICG/NIRF assessment was highly sensitive for anastomotic leaks allowing management of them intra-operatively.

Objectives are to

1. Identify if the appearances of ICG/NIRF can predict anastomotic leaks 2. Identify if the ICG/NIRF images would engender a change in operative management leading to a reduced leak rate 3. Give a detailed report on the effects of ICG on oxygen readings This would be a cohort pilot study of 20 patients with the aim of informing a subsequent multi-centre Randomised controlled trial

Recruiting

Interested in participating?

Request Info

Key information

Age range

Up to 1 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Birmingham children's hospital

Birmingham, B4 6NH, United Kingdom

Location status: Recruiting

Location contact

Max Pachl

CONTACT

About this study

Anastomotic leaks can have wide ranging consequences. If they can be predicted and/or prevented clinical outcomes for patients would be improved along with shorter length of stay and reduced cost to the national health service (NHS) in the short, medium, and long term. These patients would require less bed days both on inpatient wards and paediatric intensive care units enabling the management of other children.

This study will evaluate if ICG/NIRF tissue perfusion diagnostics can show if the fistula (distal oesophagus) end is ischaemic (has poor blood flow) prior to anastomosis. Ischaemic ends are well recognised to relate to leakage although in OA the role of mucosal apposition is poorly understood. This intervention would afford the operator the opportunity to perform a fully vascularised join if feasible and also indicate if ischaemia predicts anastomotic leaks.

It will also evaluate if post-anastomosis intravenous and enteral dosing of ICG with NIRF assessment is able to predict those who will suffer from a leak whether that be clinical or radiological.

There is little data on the effect of ICG on peripheral oxygen saturation readings, or of its effect on near infrared spectroscopy readings in neonates. This study will record the effects on peripheral saturation and near-infrared spectroscopy readings which are used routinely in babies having this type of surgery. It will compare these readings to arterial blood oxygenation readings from a blood gas analyser. Blood gases are routinely taken during this procedure and so this will not involve any extra blood testing over and above what is ordinarily performed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Pre-operative

  • Diagnosis of oesophageal atresia with distal trachea-oesophageal fistula (OA/dTOF)
  • Plan for primary or delayed primary oesophageal anastomosis

Intra-operative

  • Diagnosis of OA/dTOF confirmed by standard methods
  • Primary or delayed primary oesophageal anastomosis considered clinically, physiologically, and technically feasible

Exclusion criteria

Pre-operative

  • Under 2.5kg in weight
  • Complex cardiac disease
  • Allergic to ICG
  • Allergic to iodine or iodides
  • Hyperthyroidism
  • Chronic Kidney Disease stage V
  • Unwilling to participate
  • Those in whom exchange transfusion is indicated due to hyperbilirubinemia

Intra-operative

  • Anaesthetic concerns contra-indicating the use of intravenous ICG due its temporary effect on oxygen saturation readings prior to injection of ICG

Treatment and study plan

Indocyanine green

Drug

Intravenous and endoluminal dosing

Primary outcomes

  1. Intravenous ICG

    Time frame: Within two weeks of surgery

    Number of patients with abnormal perfusion will have a clinical and/or radiological anastomotic leak

  2. Enteral ICG

    Time frame: Within two weeks of surgery

    Number of patients in whom ICG given enterally shows an anastomotic leak

Secondary outcomes

  1. Delphi

    Time frame: Within a year following surgery

    Number of patients in whom ICG given prior to anastomosis causes a change in intra-operative plan

  2. Peripheral oxygen saturations (SpO2)

    Time frame: Within a year following surgery

    In how many patients does the intravenous injection of ICG alter the peripheral oxygenation and/or near infrared spectroscopy readings.

Study contacts

Contact information is provided by the study sponsor or research team.

Sarah Hadfield

CONTACT

[email protected]

01213339999

max pachl

CONTACT

[email protected]

01213339999

Sponsors and collaborators

Lead sponsor

Birmingham Women's and Children's NHS Foundation Trust

Other

Registry information

Official study title

Indocyanine Green (ICG) and Near Infrared Fluorescence (NIRF) Guided Assessment of the Bowel and Oesophageal Anastomosis During Repair of Oesophageal Atresia with Distal Trachea-oesophageal Fistula (OA/dTOF): a Cohort Pilot Study

Acronym: iTOF

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Feb 21, 2023
Registry last updated
Mar 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.